JLJacqueline K. Limberg

Jacqueline K. Limberg

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jacqueline K. Limberg has a total of 124 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Respiratory modulation of sympathetic activity during hypoxia in adults with overweight and obesity

    by Anna M. Gonsalves, Vina D. Vedala, Jacqueline K. Limberg, Natasha G. Boyes

    Muscle sympathetic nerve activity (MSNA) is modulated by respiration, with MSNA greatest during end-expiration (low lung volume) and lowest at peak inspiration (high lung volume). Adults with overweight/obesity exhibit enhanced inspiratory sympathoinhibition during hypoxia, resulting in amplified respiratory-sympathetic coupling, compared with adults of normal weight. Findings underscore the early implications of obesity on sympathetic activity during hypoxia before the development of overt disease (i.e., sleep apnea, chronic obstructive pulmonary disease).

  • Open Access

    Role for endothelin-1 in cardiometabolic dysfunction with intermittent hypoxia

    by Anna M. Gonsalves, Sarah E. Baker, Prachi Singh, Jacqueline K. Limberg

    Endothelin-1 (ET-1) has been linked to increased hypoxic sensitivity of the chemoreceptors and the development of cardiometabolic disease. Repeated hypoxic exposures [i.e., intermittent hypoxia (IH)] elicit increases in ET-1, muscle sympathetic nerve activity (MSNA), and blood pressure (BP). In this brief review, we summarize data from our group(s) which examined the effect of acute IH on MSNA, BP, and indices of adipose tissue lipolysis [i.e., free fatty acids (FFAs)], as well as the role of ET-1 in these responses. Herein, we show that acute ET receptor inhibition (oral bosentan) attenuates the rise in BP during hypoxia and the fall in BP during hyperoxia in healthy young men. Although the effect of IH on MSNA and BP was not attenuated following ET-receptor inhibition, IH increased plasma ET-1, epinephrine, and FFA concentrations. Notably, inhibition of ET-1 receptors with oral bosentan attenuated the IH-mediated rise in epinephrine and FFA. With these findings, we demonstrate a role for ET-1 in the maintenance of resting BP in young men, possibly through a chemoreceptor-mediated mechanism. We further speculate that the effect of ET-1 receptor inhibition on circulating FFA is secondary to its ability to reduce sympathoadrenal tone during IH exposure. Results highlighted in this review may serve as the basis for future work exploring ET-1 as a therapeutic target for cardiometabolic dysfunction associated with IH.


  • Open Access

    Sex‐related differences in the peripheral vascular response to hypoxia: Implications in health and relevance for obstructive sleep apnoea

    by Dain W. Jacob, Sara E. Mascone, Natasha G. Boyes, Anna M. Gonsalves, Jacqueline K. Limberg

    The incidence and presentation of obstructive sleep apnoea, as well as hypertension and cardiovascular disease, have been reported to differ by sex. It is thus reasonable to propose mechanisms contributing to subsequent pathology differ by sex. This concept is supported from a pre‐pathological perspective, as sex differences have been observed in the vascular response to hypoxia both alone and during concomitant hypoxia and sympathetic activation. However, the mechanisms governing the vascular response to hypoxia in females compared to males have only recently been examined, with the preponderance of data in predominantly male or all‐male cohorts. Determining the sex‐specific mechanisms contributing to the foundational vascular response to hypoxia is essential to the development of targeted therapeutics. Herein we outline literature in support of vascular sex‐related differences in the acute response to both intermittent and steady‐state hypoxia, with an emphasis on the healthy state. However, questions remain to bridge the gap between preclinical observations to pathological conditions, such as the role of sex hormones and adrenergic receptors, with increasing adiposity, age and chronic disease (e.g., sleep apnoea).


  • Sympathetic neural control of blood pressure across the premenopausal lifespan

    by Jinan Saboune, Natasha G. Boyes, Jacqueline K. Limberg, Charlotte W. Usselman

    The technique of microneurography has advanced our understanding of the sympathetic nervous system’s role in the neurovascular control of blood pressure in humans, yet critical knowledge gaps remain, particularly across the premenopausal female lifespan. Historically, premenopausal females have been considered relatively protected from cardiovascular diseases, leading to a disproportionate focus on postmenopausal populations in cardiovascular research. However, emerging evidence contradicts this assumption: premenopausal females with hypertension exhibit 15–20% higher mortality rates than age-matched males, and myocardial infarction deaths are rising fastest among females under the age of 45. This review addresses a major void in the literature by examining sympathetic regulation of blood pressure in premenopausal females and how it is modulated across unique reproductive health states, including menstrual cycling, hormonal contraceptive use, pregnancy, polycystic ovary syndrome, uterine fibroids, and endometriosis. Muscle sympathetic nerve activity fluctuates with some but not all hormonal changes, depending on the population and the conditions under which they are studied. Moreover, corresponding effects on blood pressure vary widely, suggesting a high degree of variability in how sympathetic outflow is transduced into blood pressure in females. Overall, our review highlights the need for longitudinal and mechanistic studies focused on hormonal transitions and specific premenopausal health states to better understand, and eventually mitigate, female-specific cardiovascular risk.

  • Habitual sleep duration is associated with heightened muscle sympathetic nerve activation and blood pressure reactivity in response to the cold pressor test

    by Nathaniel D. M. Jenkins, Natasha G. Boyes, Dain W. Jacob, Brian Shariffi, Samuel A. Martin, Jacqueline K. Limberg

    Recent evidence has suggested that habitual sleep duration is not strongly associated with resting sympathetic neural activity. However, the present findings suggest that habitual sleep duration is inversely associated with muscle sympathetic nerve activation and blood pressure responses to sympathoexcitatory stress. Therefore, enhanced neurocardiovascular reactivity—rather than tonic sympathetic activation—may be a more relevant pathway by which chronic insufficient sleep contributes to cardiovascular disease pathophysiology.


  • The role of α 2 -adrenergic mechanisms in sympathetic baroreflex control of human blood pressure

    by Julia E. Spafford, Jacqueline K. Limberg, Ronée E. Harvey, Chad C. Wiggins, Nathaniel J. Iannarelli, Jonathon W. Senefeld, Wayne T. Nicholson, Timothy B. Curry, Michael J. Joyner, J. Kevin Shoemaker, et al.

    Intravenous dexmedetomidine infusion (selective α 2 -adrenergic receptor agonist) 1) reduced the firing probability and strength of baroreflex control over medium-sized sympathetic action potentials in muscle sympathetic nerve activity (MSNA) and 2) attenuated the transduction of MSNA bursts to changes in blood pressure (BP) by reducing the magnitude of BP responses and increasing the time to peak BP. These data suggest that neural and vascular α 2 -adrenergic mechanisms contribute to sympathetic baroreflex regulation of human BP.


  • Resveratrol restores indices of neurovascular coupling following acute sleep restriction in young men and women

    by Matthew J. McDonald, Sharon D. Fears, Samuel A. Martin, Brian Shariffi, Todd L. Lancaster, Jill A. Kanaley, Jacqueline K. Limberg

    Herein, we demonstrate that one night of restricted sleep (4 h time in bed) impairs the link between neural activity and cerebral blood flow (i.e., neurovascular coupling, NVC) of both middle and posterior cerebral arteries, and oral resveratrol supplementation may mitigate these impairments, particularly in the posterior cerebral artery. These results enhance our mechanistic understanding of sleep-associated impairments in NVC and advance our knowledge of neurovascular dysfunction occurring after restricted sleep.

  • Role of overweight and obesity on vascular responses to the cold pressor test and hypoxia in women

    by Natasha G. Boyes, Dain W. Jacob, Brian Shariffi, Anna M. Gonsalves, Jennifer L. Harper, Brian P. Bostick, Jacqueline K. Limberg

    Sympathetic-mediated vasoconstriction is attenuated during hypoxia in young women with normal weight, demonstrating the expected hypoxic sympatholysis. Conversely, hypoxic sympatholysis is attenuated in women with increased adiposity, despite preserved sympathetic vasoconstriction and hypoxic vasodilation compared with women with normal weight. These data advance our understanding of the impact of obesity on neurovascular control of blood flow and have implications for individuals with obesity and conditions associated with hypoxia (e.g., sleep apnea).


  • β-Adrenergic receptors mediate sex differences in vasodilation but not sympathetic-mediated vasoconstriction during hypoxia

    by Dain W. Jacob, Brian Shariffi, Braden J. Bond, Natasha G. Boyes, Samuel A. Martin, Anna M. Gonsalves, Jennifer L. Harper, Brian P. Bostick, Jacqueline K. Limberg

    β-Adrenergic receptors contribute to hypoxic vasodilation, attenuate sympathetic vasoconstriction at rest, and are more sensitive in females versus males. We hypothesized β-adrenergic receptor blockade would blunt hypoxic vasodilation and augment the sympathetic vasoconstriction during hypoxia, with effects greater in females relative to males. Present data demonstrate β-adrenergic receptors contribute to hypoxic vasodilation in females but do not restrain sympathetic-mediated vasoconstriction during hypoxia in either sex.


  • Open Access

    Acute exogenous oestradiol augments endothelial and smooth muscle vasodilatory responsiveness in premenopausal but not postmenopausal females

    by Gabrielle A. Dillon, Ronée E. Harvey, Jacqueline K. Limberg, Wayne T. Nicholson, Michael J. Joyner, Sarah E. Baker, Virginia M. Miller, Sushant M. Ranadive

    Menopause is associated with vascular dysfunction. During the menopausal transition, endogenous oestradiol concentrations diminish. Oestradiol is vasoprotective because it has direct and indirect effects on the vasculature. The present study aimed to determine the effect of acute exogenous oestradiol on endothelium‐dependent, endothelium independent and β2‐adrenergic receptor‐induced vasodilatation in females. Forearm blood flow (venous occlusion plethysmography) was measured during brachial intraarterial infusions of ACh (endothelium‐dependent agonist), sodium nitroprusside (endothelium independent agonist) and terbutaline (β2‐adrenergic receptor agonist) with and without concurrent infusion of 17β‐oestradiol. Nine young premenopausal (age: 26 ± 4 years) and nine postmenopausal (PM, age: 58 ± 4 years, 8 ± 1 years post‐menopause) females completed the study. Concurrent oestradiol infusion augmented the vasodilatory response to ACh, sodium nitroprusside and terbutaline in young premenopausal (all P < 0.05) but not older postmenopausal (all P > 0.05), females. Local infusion of exogenous 17β‐oestradiol augmented endothelial and smooth muscle microvascular vasodilatation in premenopausal but not postmenopausal, females. image Key points: Menopause is associated with vascular dysfunction. Because oestradiol has vasoprotective effects, the menopause‐associated drop in oestradiol concentrations is hypothesized to contribute to vascular dysfunction during the menopause transition. The present study shows that local infusion of exogenous oestradiol augmented microvascular vasodilatation in premenopausal but not postmenopausal females.